Table of Contents Idiopathic Pulmonary Fibrosis Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025 1 Industry Overview of Idiopathic Pulmonary Fibrosis 1.1 Idiopathic Pulmonary Fibrosis Market Overview 1.1.1 Idiopathic Pulmonary Fibrosis Product Scope 1.1.2 Market Status and Outlook 1.2 Global Idiopathic Pulmonary Fibrosis Market Size and Analysis by Regions 1.2.1 North America 1.2.2 Europe 1.2.3 China 1.2.4 Rest of Asia Pacific 1.2.5 Central & South America 1.2.6 Middle East & Africa 1.3 Idiopathic Pulmonary Fibrosis Market by Type 1.3.1 Systemic Corticosteroids 1.3.2 Immunosuppressant Drugs 1.3.3 Tyrosine Kinase Inhibitors 1.3.4 Antifibrotic Agents 1.4 Idiopathic Pulmonary Fibrosis Market by End Users/Application 1.4.1 Hospitals 1.4.2 Clinics 1.4.3 Ambulatory Surgical Centers 1.4.4 Academic and Research Organizations 2 Global Idiopathic Pulmonary Fibrosis Competition Analysis by Players 2.1 Idiopathic Pulmonary Fibrosis Market Size (Value) by Players (2018 and 2019) 2.2 Competitive Status and Trend 2.2.1 Market Concentration Rate 2.2.2 Product/Service Differences 2.2.3 New Entrants 2.2.4 The Technology Trends in Future 3 Company (Top Players) Profiles 3.1 MediciNova 3.1.1 Company Profile 3.1.2 Main Business/Business Overview 3.1.3 Products, Services and Solutions 3.1.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.1.5 Recent Developments 3.2 Boehringer Ingelheim 3.2.1 Company Profile 3.2.2 Main Business/Business Overview 3.2.3 Products, Services and Solutions 3.2.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.2.5 Recent Developments 3.3 F. Hoffmann-La Roche 3.3.1 Company Profile 3.3.2 Main Business/Business Overview 3.3.3 Products, Services and Solutions 3.3.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.3.5 Recent Developments 3.4 FibroGen 3.4.1 Company Profile 3.4.2 Main Business/Business Overview 3.4.3 Products, Services and Solutions 3.4.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.4.5 Recent Developments 3.5 Promedior 3.5.1 Company Profile 3.5.2 Main Business/Business Overview 3.5.3 Products, Services and Solutions 3.5.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.5.5 Recent Developments 3.6 Merck 3.6.1 Company Profile 3.6.2 Main Business/Business Overview 3.6.3 Products, Services and Solutions 3.6.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.6.5 Recent Developments 3.7 Galapagos 3.7.1 Company Profile 3.7.2 Main Business/Business Overview 3.7.3 Products, Services and Solutions 3.7.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.7.5 Recent Developments 3.8 Prometic Life Sciences 3.8.1 Company Profile 3.8.2 Main Business/Business Overview 3.8.3 Products, Services and Solutions 3.8.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.8.5 Recent Developments 3.9 Cipla 3.9.1 Company Profile 3.9.2 Main Business/Business Overview 3.9.3 Products, Services and Solutions 3.9.4 Idiopathic Pulmonary Fibrosis Revenue (Value) (2014-2019) 3.9.5 Recent Developments 4 Global Idiopathic Pulmonary Fibrosis Market Size by Type and Application (2014-2019) 4.1 Global Idiopathic Pulmonary Fibrosis Market Size by Type (2014-2019) 4.2 Global Idiopathic Pulmonary Fibrosis Market Size by Application (2014-2019) 4.3 Potential Application of Idiopathic Pulmonary Fibrosis in Future 4.4 Top Consumer/End Users of Idiopathic Pulmonary Fibrosis 5 North America Idiopathic Pulmonary Fibrosis Development Status and Outlook 5.1 North America Idiopathic Pulmonary Fibrosis Market Size (2014-2019) 5.2 North America Idiopathic Pulmonary Fibrosis Market Size and Market Share by Players (2018 and 2019) 6 Europe Idiopathic Pulmonary Fibrosis Development Status and Outlook 6.1 Europe Idiopathic Pulmonary Fibrosis Market Size (2014-2019) 6.2 Europe Idiopathic Pulmonary Fibrosis Market Size and Market Share by Players (2018 and 2019) 7 China Idiopathic Pulmonary Fibrosis Development Status and Outlook 7.1 China Idiopathic Pulmonary Fibrosis Market Size (2014-2019) 7.2 China Idiopathic Pulmonary Fibrosis Market Size and Market Share by Players (2018 and 2019) 8 Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Development Status and Outlook 8.1 Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Size (2014-2019) 8.2 Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Size and Market Share by Players (2018 and 2019) 9 Central & South America Idiopathic Pulmonary Fibrosis Development Status and Outlook 9.1 Central & South America Idiopathic Pulmonary Fibrosis Market Size (2014-2019) 9.2 Central & South America Idiopathic Pulmonary Fibrosis Market Size and Market Share by Players (2018 and 2019) 10 Middle East & Africa Idiopathic Pulmonary Fibrosis Development Status and Outlook 10.1 Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size (2014-2019) 10.2 Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size and Market Share by Players (2018 and 2019) 11 Market Forecast by Regions, Type and Application (2019-2025) 11.1 Global Idiopathic Pulmonary Fibrosis Market Size (Value) by Regions (2019-2025) 11.1.1 North America Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2019-2025) 11.1.2 Europe Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2019-2025) 11.1.3 China Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2019-2025) 11.1.4 Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2019-2025) 11.1.5 Central & South America Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2019-2025) 11.1.6 Middle East & Africa Idiopathic Pulmonary Fibrosis Revenue and Growth Rate (2019-2025) 11.2 Global Idiopathic Pulmonary Fibrosis Market Size (Value) by Type (2019-2025) 11.3 Global Idiopathic Pulmonary Fibrosis Market Size by Application (2019-2025) 12 Idiopathic Pulmonary Fibrosis Market Dynamics 12.1 Idiopathic Pulmonary Fibrosis Market Opportunities 12.2 Idiopathic Pulmonary Fibrosis Challenge and Risk 12.2.1 Competition from Opponents 12.2.2 Downside Risks of Economy 12.3 Idiopathic Pulmonary Fibrosis Market Constraints and Threat 12.3.1 Threat from Substitute 12.3.2 Government Policy 12.3.3 Technology Risks 12.4 Idiopathic Pulmonary Fibrosis Market Driving Force 12.4.1 Growing Demand from Emerging Markets 12.4.2 Potential Application 13 Market Effect Factors Analysis 13.1 Technology Progress/Risk 13.1.1 Substitutes 13.1.2 Technology Progress in Related Industry 13.2 Consumer Needs Trend/Customer Preference 13.3 External Environmental Change 13.3.1 Economic Fluctuations 13.3.2 Other Risk Factors 14 Research Finding/Conclusion 15 Appendix Methodology Analyst Introduction Data Source

List of Tables and Figures Figure Idiopathic Pulmonary Fibrosis Product Scope Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) (2014-2019) Table Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Idiopathic Pulmonary Fibrosis Market Share by Regions in 2018 Figure North America Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Europe Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure China Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Central & South America Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Figure Global Idiopathic Pulmonary Fibrosis Market Share by Type in 2018 Figure Systemic Corticosteroids Market Size (Million USD) and Growth Rate (2014-2019) Figure Immunosuppressant Drugs Market Size (Million USD) and Growth Rate (2014-2019) Figure Tyrosine Kinase Inhibitors Market Size (Million USD) and Growth Rate (2014-2019) Figure Antifibrotic Agents Market Size (Million USD) and Growth Rate (2014-2019) Figure Global Idiopathic Pulmonary Fibrosis Market Share by Application in 2018 Table Key Downstream Customer in Hospitals Figure Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate in Hospitals (2014-2019) Table Key Downstream Customer in Clinics Figure Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate in Clinics (2014-2019) Table Key Downstream Customer in Ambulatory Surgical Centers Figure Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate in Ambulatory Surgical Centers (2014-2019) Table Key Downstream Customer in Academic and Research Organizations Figure Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate in Academic and Research Organizations (2014-2019) Table Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Players (2018 and 2019) Figure Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2018 Figure Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2019 Table MediciNova Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of MediciNova (2014-2019) Figure MediciNova Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table Boehringer Ingelheim Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of Boehringer Ingelheim (2014-2019) Figure Boehringer Ingelheim Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table F. Hoffmann-La Roche Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of F. Hoffmann-La Roche (2014-2019) Figure F. Hoffmann-La Roche Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table FibroGen Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of FibroGen (2014-2019) Figure FibroGen Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table Promedior Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of Promedior (2014-2019) Figure Promedior Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table Merck Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of Merck (2014-2019) Figure Merck Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table Galapagos Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of Galapagos (2014-2019) Figure Galapagos Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table Prometic Life Sciences Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of Prometic Life Sciences (2014-2019) Figure Prometic Life Sciences Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 2018 Table Cipla Basic Information List Table Idiopathic Pulmonary Fibrosis Business Revenue (Million USD) of Cipla (2014-2019) Figure Cipla Idiopathic Pulmonary Fibrosis Business Revenue Market Share in 20187 Table Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Type (2014-2019) Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2014 Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2015 Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2016 Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2017 Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2018 Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2019 Table Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application (2014-2019) Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2014 Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2015 Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2015 Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2017 Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2018 Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2019 Table Top Consumer/End Users of Idiopathic Pulmonary Fibrosis Figure North America Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table North America Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Players (2014-2019) Figure North America Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2018 Figure North America Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2019 Figure Europe Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Europe Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Players (2014-2019) Figure Europe Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2018 Figure Europe Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2019 Figure China Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table China Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Players (2014-2019) Figure China Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2018 Figure China Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2019 Figure Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Players (2014-2019) Figure Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2018 Figure Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2019 Figure Central & South America Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Central & South America Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Players (2014-2019) Figure Central & South America Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2018 Figure Central & South America Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2019 Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size (Million USD) and Growth Rate by Regions (2014-2019) Table Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Players (2014-2019) Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2018 Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Market Size Share by Players in 2019 Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Regions (2019-2025) Table Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Regions (2019-2025) Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Regions in 2019 Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Regions in 2025 Figure North America Idiopathic Pulmonary Fibrosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Europe Idiopathic Pulmonary Fibrosis Revenue (Million USD) and Growth Rate (2019-2025) Figure China Idiopathic Pulmonary Fibrosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Rest of Asia Pacific Idiopathic Pulmonary Fibrosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Central & South America Idiopathic Pulmonary Fibrosis Revenue (Million USD) and Growth Rate (2019-2025) Figure Middle East & Africa Idiopathic Pulmonary Fibrosis Revenue (Million USD) and Growth Rate (2019-2025) Table Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Type (2019-2025) Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2019 Figure Global Idiopathic Pulmonary Fibrosis Market Size Share by Type in 2025 Table Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application (2019-2025) Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2019 Figure Global Idiopathic Pulmonary Fibrosis Market Size (Million USD) by Application in 2025

MediciNova Boehringer Ingelheim F. Hoffmann-La Roche FibroGen Promedior Merck Galapagos Prometic Life Sciences Cipla